ADD CONDITION

items per page

A and E Deep Throat Desensitizing Spraypeppermint

Last content change checked dailysee data sync status

Active ingredient
Benzocaine 3 mg/100 mL
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2025
Label revision date
November 11, 2025
Active ingredient
Benzocaine 3 mg/100 mL
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2025
Label revision date
November 11, 2025
Manufacturer
Phe Inc
Registration number
M017
NDC root
87068-182

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This medication is designed for occasional personal use to help prevent the gag reflex, which can be helpful in various situations. It works by providing support to manage this reflex, making certain activities more comfortable for you. If you have concerns or questions about how it may work for your specific needs, it's always a good idea to consult with a healthcare professional.

Uses

You can use this medication occasionally to help prevent the gag reflex, which can be helpful in certain situations. It's important to note that there are no reported teratogenic effects (harmful effects on a developing fetus) associated with this medication, so it is considered safe in that regard. Additionally, there are no nonteratogenic effects (effects that do not harm fetal development) mentioned, indicating that the medication is generally well-tolerated.

Dosage and Administration

When using this medication, you should apply 2 to 3 sprays directly to the back of your throat. It's important to limit your use to no more than 3 to 4 times a day. This medication is intended for adults aged 18 years and older, so please remember that it is not suitable for minors. Always follow these guidelines to ensure safe and effective use.

What to Avoid

It's important to keep this medication out of reach of children to ensure their safety. There are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. Always follow safety guidelines to use it responsibly.

Side Effects

Using this product may lead to a serious condition called methemoglobinemia, which reduces the amount of oxygen in your blood. This can happen even if you have used the product before. If you or a child in your care experiences symptoms such as pale, gray, or blue skin (known as cyanosis), headache, rapid heart rate, shortness of breath, dizziness, or fatigue, it is important to stop using the product and seek immediate medical attention.

Warnings and Precautions

Using this product may lead to a serious condition called methemoglobinemia, which reduces the amount of oxygen in your blood. This can happen even if you have used the product before. If you or a child in your care experiences any of the following symptoms, stop using the product immediately and seek emergency medical help: pale, gray, or blue skin (known as cyanosis), headache, rapid heart rate, shortness of breath, dizziness or lightheadedness, and fatigue or lack of energy.

It's crucial to be aware of these signs and act quickly. If you notice any of these symptoms, do not hesitate to stop using the product and contact a healthcare professional right away. Your health and safety are the top priority.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's always important to be aware of the signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect that you or someone else may have taken too much of a medication, it’s crucial to seek immediate medical help.

In case of an overdose, contact your local emergency services or go to the nearest hospital right away. Having the medication packaging or details on hand can help healthcare professionals provide the best care. Always remember that when it comes to medications, it's better to be safe and get help if you have any concerns.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to be aware that there is no specific information available regarding the use of this medication during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions have not been established.

Before taking this medication, you should consult with your healthcare provider to discuss any potential risks and to ensure that you are making informed decisions for your health and the health of your baby. Always prioritize open communication with your doctor about any medications you are considering during pregnancy.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or considerations mentioned regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. However, it's always a good idea to consult with your healthcare provider if you have any concerns or questions about your specific situation.

Pediatric Use

It's important to keep this medication out of reach of children. If you notice any concerning symptoms in your child, such as pale, gray, or blue skin (known as cyanosis), headache, rapid heart rate, shortness of breath, dizziness, or unusual fatigue, stop using the medication immediately and seek medical help.

This medication is intended for adults only and should not be given to minors. Always prioritize safety and consult with a healthcare professional if you have any questions or concerns regarding its use.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. If you or a loved one is an older adult, it’s always wise to discuss any medications with a healthcare provider, especially since older individuals may have different health needs and responses to treatments.

Since there are no dosage adjustments or safety concerns specifically noted for elderly patients, your healthcare provider can help determine the best approach based on individual health conditions and any other medications being taken. Always prioritize open communication with your doctor to ensure safe and effective use of any medication.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations for patients with renal impairment (kidney issues) are not provided.

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver condition and how it relates to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. Currently, there are no known interactions between this medication and other drugs or laboratory tests. However, your healthcare provider can help ensure that your treatment plan is safe and effective, taking into account your unique health needs and any other medications you might be using. Always feel free to ask questions and share your complete medical history to help avoid any potential issues.

Storage and Handling

To ensure the best performance of your product, store it at a temperature between 20-25°C (68-77°F). This temperature range helps maintain its effectiveness and safety.

When handling the product, be sure to do so with care to avoid any damage. Always follow any specific instructions provided for use and disposal to ensure safety and compliance.

Additional Information

You should apply 2-3 sprays of this product to the back of your throat, and limit its use to 3-4 times a day if you are an adult aged 18 or older. It's important to be aware that this product may cause a serious condition called methemoglobinemia, which reduces the amount of oxygen in your blood. This can happen even if you've used the product before. If you or a child in your care experiences symptoms like pale, gray, or blue skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness, or fatigue, stop using the product and seek immediate medical attention.

Always keep this product out of reach of children. In case of accidental overdose or ingestion, contact a Poison Control Center for assistance.

FAQ

What is the primary use of this drug?

This drug is for occasional personal use to help prevent the gag reflex.

Who can use this drug?

This drug is intended for adults 18 years of age and older only.

How should I use this drug?

You should apply 2-3 sprays to the back of your throat, limiting use to 3-4 times per day.

Are there any warnings associated with this drug?

Yes, the drug may cause methemoglobinemia, a serious condition that reduces oxygen in the blood. Seek immediate medical attention if you or a child develops symptoms like pale skin, headache, or shortness of breath.

What should I do if I experience serious side effects?

Stop using the drug and seek immediate medical help if you or a child shows symptoms such as cyanosis, rapid heart rate, or dizziness.

Is this drug safe for use during pregnancy or while nursing?

There are no specific warnings or considerations mentioned regarding use during pregnancy or lactation.

How should I store this drug?

Store the drug at 20-25°C (68-77°F).

What should I do if a child accidentally ingests this drug?

Keep the drug out of reach of children and contact a Poison Control Center for guidance.

Packaging Info

Below are the non-prescription pack sizes of A and E Deep Throat Desensitizing Spraypeppermint (oral numbing spray mint). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for A and E Deep Throat Desensitizing Spraypeppermint.
Details

Drug Information (PDF)

This file contains official product information for A and E Deep Throat Desensitizing Spraypeppermint, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for occasional personal use to help prevent the gag reflex.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults aged 18 years and older, the recommended dosage is to apply 2 to 3 sprays to the back of the throat. Administration should be limited to a maximum of 3 to 4 times per day. This product is intended for adult use only and is not approved for sale to minors.

Contraindications

There are no specific contraindications associated with this product. However, it is advised to keep the product out of reach of children to prevent accidental ingestion or misuse.

Warnings and Precautions

The use of this product carries a risk of methemoglobinemia, a serious condition characterized by a reduced capacity of blood to carry oxygen. This condition can manifest even in individuals who have previously used the product without incident. Healthcare professionals should advise patients to discontinue use and seek immediate medical attention if they or a child in their care exhibit any of the following symptoms:

  • Pale, gray, or blue-colored skin (cyanosis)

  • Headache

  • Rapid heart rate

  • Shortness of breath

  • Dizziness or lightheadedness

  • Fatigue or lack of energy

Prompt recognition and treatment of these symptoms are critical to prevent potential complications associated with methemoglobinemia. It is essential for healthcare providers to monitor patients closely for these signs, particularly in those who may be at higher risk.

Side Effects

The use of this product may lead to methemoglobinemia, a serious condition characterized by reduced oxygen transport in the blood. This adverse reaction can occur even in patients who have previously used the product without incident. It is crucial for patients and caregivers to be vigilant for symptoms indicative of methemoglobinemia, which include pale, gray, or blue-colored skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness or lightheadedness, and fatigue or lack of energy. In the event that any of these symptoms develop, immediate medical attention should be sought to ensure prompt treatment.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of A and E Deep Throat Desensitizing Spraypeppermint (oral numbing spray mint). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for A and E Deep Throat Desensitizing Spraypeppermint.
Details

Pediatric Use

Pediatric patients should not have access to this medication, and it must be kept out of reach of children. The use of this medication is contraindicated in individuals under the age of 18, as it is intended for adult use only.

Healthcare professionals should advise caregivers to stop use and seek immediate medical attention if a child in their care develops any of the following symptoms: pale, gray, or blue-colored skin (cyanosis), headache, rapid heart rate, shortness of breath, dizziness or lightheadedness, or fatigue or lack of energy.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients and weigh the potential risks and benefits. Women of childbearing potential should be counseled on the absence of established safety data and the importance of discussing any potential pregnancy with their healthcare provider.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns related to breastfeeding. However, as with any medication, it is advisable to monitor breastfed infants for any potential adverse effects.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important for patients to understand the potential risks associated with accidental overdose or ingestion. In such cases, they should be instructed to contact a Poison Control Center immediately for guidance and assistance. This information is crucial for ensuring the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 20-25°C (68-77°F) to maintain its integrity and efficacy. Proper storage conditions should be ensured to prevent exposure to extreme temperatures, which may compromise the product's quality.

Additional Clinical Information

Patients aged 18 years and older are instructed to apply 2-3 sprays to the back of the throat, with a maximum frequency of 3-4 times per day. Clinicians should counsel patients about the risk of methemoglobinemia, a serious condition that can reduce oxygen levels in the blood. Symptoms may include cyanosis (pale, gray, or blue skin), headache, rapid heart rate, shortness of breath, dizziness, or fatigue. Patients should be advised to discontinue use and seek immediate medical attention if these symptoms occur. Additionally, the product should be kept out of reach of children, and in the event of accidental overdose or ingestion, a Poison Control Center should be contacted.

Drug Information (PDF)

This file contains official product information for A and E Deep Throat Desensitizing Spraypeppermint, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for A and E Deep Throat Desensitizing Spraypeppermint, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.